Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Remitogen

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Multiple myeloma (MM) is the second most commonly diagnosed hematologic malignancy after non-Hodgkin lymphoma and remains… Expand
Is this relevant?
Review
2003
Review
2003
Dr. Nabhan and his coauthors have written a comprehensive review of the use of monoclonal antibodies in the treatment of chronic… Expand
Is this relevant?
2002
2002
The humanized monoclonal antibody Hu1D10 (Remitogen™3;, Protein Design Labs, Fremont, CA) recognizes a polymorphic determinant of… Expand
Is this relevant?
2002
2002
Antibody-based approaches have become a novel treatment modality for lymphoma patients. Humanized 1D10 (Hu1D10; Remitogen) is… Expand
Is this relevant?
2002
2002
  • Expert review of anticancer therapy
  • 2002
  • Corpus ID: 34566663
 
Is this relevant?